The warning upped the stakes in the industry’s fight against the drug-pricing measure in President Biden’s $3.5 trillion social welfare bill, which they previously argued would hamper drugmakers’ ability to create new cures.https://t.co/hShIadWGJQ
— The Washington Times (@WashTimes) September 9, 2021